Poultry Vaccines Market Size is forecasted to grow by 2032

Market Highlights

The Poultry Vaccines Market Size was worth USD 1.8 billion in 2022 and is expected to reach USD 3.32 billion by 2032 at 7.05% CAGR during the forecast period 2023 to 2032.

The high cost associated with poultry vaccines, lack of awareness regarding poultry vaccines, and unaffordability of veterinary services in underdeveloped and developing regions may hamper the growth of the Poultry Vaccines Market Share during the assessment period. For instance, according to the National Institute of Standards and Technology (NIST), in January 2016, more than 35.0% of vaccines lost their potency during the global shipping, as they were stored at temperatures that were either too high or too low.

Key Players

Some of the key Poultry Vaccines Market Players are

Boehringer Ingelheim,

Elanco,

MSD & Co.,

Zoetis Inc,

Ceva Animal Health Inc.,

Phibro Animal Health Corporation,

Virbac,

Hipra,

Venkys,

Biovet, and

Anicon GmbH, and

Others.

Segmentation

The global Poultry Vaccines Market Report has been segmented based on diseases, technology, dosage form and region.

·       Based on disease, the market has been classified as infectious bronchitis, avian influenza, marek's disease, newcastle disease, and others. the market, by technology, has been segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines, live attenuated vaccines (lav), and others. based on dosage form, the market has been segmented into duct vaccines, liquid vaccines, and freeze-dried vaccines.

·       Based on technology, live attenuated vaccines segment is expected to hold the largest market share of the poultry vaccines market during the forecast period. Also, recombinant vaccines segment to register the fastest growth in the global poultry vaccines market during the forecast period.

Regional Analysis

The Poultry Vaccines Market Outlook is likely to dominate by Americas during the forecast period owing to the awareness about the prevention of animal-to-human transmission diseases, rising demand for safe animal food supply, and increasing investment in research and development for animal vaccines. Moreover, high expenditure spending and favorable reimbursement policy also fueling the growth of the market during forecast periods. The European market is expected to be the second-largest due to government support for research & development and improved animal husbandry practices. However, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to rising awareness and increase in the number of animal welfare programs. The market in the Middle East & Africa is likely to account for the smallest share of the global poultry vaccines market.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Hair Removal Devices Market Size, Strategies & Key Players Review by Forecast to 2032

Overview:

The Hair Removal Devices Market Size exhibiting a compound annual growth rate (CAGR) of 9.8% during the forecast period (2023 - 2032). Market Research Future (MRFR) considers several factors like fashion, sports, cultural practices, military, medical reasons, and others as prominent growth-inducing avenues for the market. The easy availability of these products through retail and e-commerce lines strongly denotes hair removal devices market trends and better awareness regarding the product can boost the market prospect.

Competitive Landscape:

The global hair removal devices market players growth can benefit substantially from various companies like

Sciton, Inc,

Alma Lasers, Ltd.,

Syneron Medical Ltd.,

Cutera Inc.,

Cynosure, Inc.,

Lynton Lasers Ltd,

Solta Medical Inc.,

Strata Skin Sciences, Inc.,

Lumenis Ltd,

Lutronic Corporation, and

Venus Concept Canada Corp.

These companies have done research works and have set their own growth policies to establish a strong outcome for themselves. The global market is slated to benefit from their mergers, acquisitions, collaborations, hike in research activities, better investment in research and development projects, and others are expected to steer the market towards innovations. MRFR recorded these recent moves to get their hands on various prospects in the coming days.

Segmentation:

MRFR’s analysis of the global hair removal devices market leads to an in-depth segmentation of product and end-user. These segments have multiple inputs from various factors that help in gaining insights and developing better marketing strategies.

·        By products, the global market for hair removal devices can be segmented into laser devices, intense pulse light (IPL) devices, energy-based devices, and others. The laser devices segment includes Nd: YAG laser, diode laser, and alexandrite laser. The laser devices segment had the maximum market share in 2017 and it is getting more traction from wider acceptance of the devices. The product is also performing better than other devices.

·        By end-users, the global report on the hair removal devices market comprises beauty clinics, home use, dermatology clinics, and others. The beauty clinics segment had the largest market share in 2017 owing to its huge women customer base.

Regional Analysis:

The Americas is expected to make huge profit in the coming years in the hair removal devices market. This is primarily due to the high investment capacity, better disposable income standards, increasing launch of innovative products, and others. The US and Canada are performing better. In Europe, this growth would be backed by the growing sale in France, Germany, Italy, Spain, and the UK. In Asia Pacific, China, India, Japan, and South Korea are expected to boost the market traction. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Cardiovascular Ultrasound Market Size, growth, drivers and forecast research report 2032

Market overview

Cardiovascular ultrasound or imaging allows healthcare professionals to monitor changes in heart structure to detect the presence of any abnormality or medical conditions such as diabetes, hypertension or other cardiovascular diseases. The global cardiovascular ultrasound market size is estimated to strike a CAGR of 6.3% over the forecast period of 2023-2032, predicts Market Research Future (MRFR). After extensively analyzing the market MRFR expects the global cardiovascular ultrasound market to grow up to USD 3.20 billion by forecast perioed.

Cardiovascular diseases continue to be among the top reasons for hospitalization and deaths across the globe. Surging prevalence of heart diseases requires early detection of such diseases to allow physicians to provide timely treatment. The global cardiovascular ultrasound market is expanding against the backdrop of an alarming increase in the incidence rate of heart diseases. Cardiovascular ultrasound techniques such as echocardiography, angiography, nuclear cardiac imaging, computed tomography, cardiac positron emission tomography (cardiac PET) and cardiac magnetic resonance imaging (cardiac MRI) are extensively used for the determination of any abnormalities. Not only are these methods effective but also non-invasive which has led to increased adoption of these methods.

Increasing patient pool suffering from diabetes is also a key factor in enhancing the growth of the market. Diabetic people are at a higher risk of developing cardiac diseases and induce greater demand within the market. Improving reimbursement scenario further creates a conducive environment for the growth of the market.

The governments in various countries, especially the emerging nations are incurring heavy expenditure on the development of healthcare infrastructure and are heavily investing in such healthcare technology which boosts the market growth.

Introduction of promising technologies such as coronary computed tomography (CT) angiography and others are also facilitating market growth. Moreover, medical device manufacturers are investing substantially in R&D activities. Various novel devices have received approval from regulatory bodies such as the FDA, and many more are in the pipeline. This is likely to augment the growth of the market over the forecast period.

Cardiovascular ultrasound or imaging devices are subject to strict monitoring by the FDA and other regulatory bodies which can constrain the market growth over the forecast period. Moreover, cardiovascular ultrasound tools are expensive and diagnostic tests result in burgeoning healthcare costs which can impede the growth of the market in price-sensitive regions. 

Regional Analysis

By region, the global cardiovascular ultrasound market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

North America is the largest market for cardiovascular ultrasound market. High prevalence of cardiovascular diseases and robust healthcare infrastructure supports the growth of the market in the region. Moreover, high healthcare expenditure, favorable reimbursement policies, and the presence of various medical device manufacturers in the region also acts as a plus for the growth of the market.

APAC is expected to be the fastest growing market for cardiovascular ultrasound market. Surging prevalence of cardiovascular diseases and the presence of a massive patient pool are factors driving growth within the APAC market. In addition, diabetes is also a common prevalent condition in the region which exposes patients at greater risk of acquiring heart diseases. High expenditure on healthcare infrastructure and government support for the same us fostering the growth of the market in the region.

Competitive Landscape

Philips Healthcare (The Netherlands), Toshiba Medical Systems Corporation (Japan), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and GE Healthcare (U.S.) are the key players in the global cardiovascular ultrasound market.

Segmentation

The global cardiovascular ultrasound market has been segmented based on type of imaging, imaging technology, and end user.

By type of imaging, the global cardiovascular ultrasound market has been segmented into transthoracic, trans esophageal, echocardiograms, stress, and abdominal vasculature ultrasound imaging.

By imaging technology, the global cardiovascular ultrasound market has been segmented into 2D, 3D and Color Doppler.

By end user, the global cardiovascular ultrasound market has been segmented into hospitals and clinics, diagnostic centers and others.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Prothrombin Complex Concentrate Market: A Comprehensive Analysis

The Prothrombin Complex Concentrate (PCC) market is segmented by region into North America, Europe, Asia Pacific, and South and Central America.

Europe is the second-largest market for PCC, with a market share of over 30% in 2023. The market is driven by similar factors as North America, including the high prevalence of bleeding disorders and the increasing use of anticoagulants.

Asia Pacific is the fastest-growing market for PCC, with a CAGR of over 12% expected during the forecast period. The growth of the market is being driven by the rising incidence of bleeding disorders and the increasing awareness of PCC among healthcare professionals.

Subscribe to get Comprehensive Data Insights:

South and Central America is the smallest market for PCC, with a market share of less than 10% in 2023. The market is expected to grow at a moderate CAGR during the forecast period, driven by the increasing prevalence of bleeding disorders and the rising demand for PCC from hospitals and clinics.

North America PCC Market is the largest market in globe, accounting of the global market share. The high prevalence of bleeding disorders in the region, such as hemophilia and liver disease, is a major driver of the market. Additionally, the increasing prescription of anticoagulants, such as warfarin, is also fueling the demand for PCC.

Overall, the global PCC market is expected to grow at a CAGR during the forecast period. The growth of the market will be driven by the increasing prevalence of bleeding disorders, the rising use of anticoagulants, and the growing awareness of PCC among healthcare professionals.

Here are some specific trends that are driving the growth of the PCC market in each region:

North America:

• The increasing prevalence of hemophilia A and hemophilia B, the two most common types of hemophilia.
• The rising use of anticoagulants, such as warfarin and dabigatran, to prevent blood clots.
• The growing awareness of PCC among healthcare professionals.

Europe:

• The increasing prevalence of liver disease, which is a major risk factor for bleeding disorders.
• The rising use of anticoagulants, such as warfarin and rivaroxaban.
• The growing availability of reimbursed PCC products.

Asia Pacific:

• The rapidly aging population, which is more susceptible to bleeding disorders.
• The rising incidence of chronic diseases, such as liver disease and cancer, which can increase the risk of bleeding.
• The increasing awareness of PCC among healthcare professionals.

South and Central America:

• The growing prevalence of hemophilia and other bleeding disorders.
• The rising use of anticoagulants.
• The increasing availability of PCC products in the region.

Related Charts:

Europe Prothrombin Complex Concentrate (PCC) Market Outlook (2018 to 2032) 

Asia Pacific Prothrombin Complex Concentrate (PCC) Market Outlook (2018 to 2032) 

Latin America Prothrombin Complex Concentrate (PCC) Market Outlook (2018 to 2032) 

Middle East & Africa Prothrombin Complex Concentrate (PCC) Market Outlook (2018 to 2032) 

About Us

Wantstats Research and Media Pvt Ltd is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. WRMPL’s approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.

Our fast growing industry research firm is backed by a proficient team of research analysts that offers valuable analytics and data with respect to technological and economical advancements. Our deemed analysts perform industrial visits and procure the relevant information from prominent market players. Our key objective is to keep our clients abridged of the potential opportunities and challenges in different markets. We provide step-by-step assistance to our respected clients, via strategic and consulting services to reach a managerial and actionable decision.

Contact Details

Corporate Office (India)

WantStats Research and Media Pvt. Ltd.

Office No 104, Pentagon 4,

Magarpatta City, Pune - 411028

Maharashtra, India.

Sales: +1 (855) 661-4441 (US)   +44 1720 412 167(UK)

Surgical Drills Market Growth, Opportunities, Ongoing Trends to 2032

Surgical Drills Market Highlights

Various factors are propelling the surgical drills market growth. Some of these factors according to the Market Research Future report, include rising medical tourism, growing elderly population, changing lifestyle, changing eating habits of consumers, excessive alcohol consumption, rising number of dental and orthopedic surgeries, and rising awareness about dental hygiene. Additional factors pushing market growth include high disposable income, increasing prevalence of chronic diseases which need surgical procedures, upgrading of healthcare equipment and infrastructure, and constant development in surgical drill technology.

Surgical Drills Market Size was valued at USD 0.9 billion in 2022 and is projected to grow from USD 0.95 Billion in 2023 to USD 1.50 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period (2023 - 2032).

A surgical drill, simply put, is a device used for boring holes in bone for attaching screws, plates, or surgical pins or reshaping teeth and removing decay for a filling. These precision instruments help to accommodate different drill bits for catering an array of applications in anything from neurological to dental surgeries. Surgical drills have an extensive range of applications, including ENT, dental surgeries, neurosurgery, orthopedic surgery, and much more.

On the contrary, scarcity of skilled medical professional and severe government regulations are factors that may restrict the surgical drills market growth over the forecast period.

Key Players

The surgical drills market players report include Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic plc, DePuy Synthes, De Soutter Medical, CONMED Corporation, B.Braun Melsungen AG, AlloTech Co.Ltd. Arthrex Inc., and Adeor medical AG, among others.

Regional Analysis

Based on the region, the surgical drills market report covers the latest trends and growth opportunities across Europe, the Asia Pacific, the Americas, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. This is owing to developed healthcare infrastructure, high physician and patient awareness about efficiency and safety of surgical drills, and an increasing number of orthopedic surgeries. Moreover, increasing awareness regarding dental hygiene, advanced treatment procedures, high disposable income, and state-of-the-art medical infrastructure are also boosting the market growth in this region.

The surgical drills market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly due to the rising support from the government for device manufacturers.

The surgical drills market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to increase in medical tourism, rising awareness among people about healthcare and surgical devices, improved healthcare infrastructure, growing medical sector, rise in government funding for healthcare, increasing medical device companies, and rising research and development expenditure.

The global surgical drills market in the Middle East and Africa is predicted to have minor growth over the forecast period.

Market Segmentation

The MRFR report offers a wide segmental analysis of the surgical drills market outlook based on application, product, and end user.

Based on products, the surgical drills market is segmented into accessories, battery-powered drills, electric drills, pneumatic drills, and others. Of these, the pneumatic drills segment will have the largest share in the market over the forecast period.

Based on application, the surgical drills market is segmented into dental surgery, ENT, neurosurgery, orthopedic surgery, and others. Of these, the orthopedic surgery segment will dominate the market over the forecast period.

Based on end users, the surgical drills market is segmented into academic and research institutes, ambulatory surgical centres, hospitals and clinics, and others. Among these, the hospitals and clinics segment will lead the market over the forecast period.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Prefilled Syringes Market Trends, Overview & Size by 2032

Prefilled Syringes Market Overview 

Market Research Future (MRFR) studied the global prefilled syringes market Size valued at USD 79.5 billion in 2022 and is projected to grow from USD 83.6 Billion in 2023 to USD 1124.59 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% during the forecast period (2023 - 2032). 

The minimal drug wastage achieved through the increased in the utility of prefilled syringes has opened an attractive option for the growing pharmaceutical sector to invest. This is expected to promote the prefilled syringe market in the study period. The benefit of self-administration of medication offered by these syringes has increased its consumer based, thereby contributing to the overall growth of the prefilled syringe market.

The biologics and biosimilars sectors are observed as another major promoters of the prefilled syringe market. Other causes that are expected to propel the prefilled syringe Prefilled Syringes Market Insights are persistence of chronic diseases over a long time that necessitate the regular administration of drugs. Increase in chronic diseases, such as diabetes, is identified to enhance the development of prefilled syringes for parenteral drug delivery is the preferred route of administration for insulin. Ease of use and dosing errors elimination benefits offered prefilled syringe, along with the causes can favor the market. Greater dose precision, simplicity in design, and suitability for home use are other advantages of prefilled syringe that is expected to promote the market during the analysis period.

The utility of prefilled syringes for different therapeutics applications, other than conventional uses, such as vaccine dispensing, has also triggered the demand for the market. The rapid development of the medical industry over the past few years is also likely to contribute significantly to the rise of the market. In addition, the increase in demand for convenient drug delivery methods has paved way for the development of the market. This is due to the pharmaceutical industry pursues modern and more effective methods for introduction solutions for convenient administration of unit dose medication.

Prefilled syringes are disposable syringes that are already loaded with liquid medicine. They are used for many therapeutic biologic formulations, especially for expensive drugs or low volumes. They have benefits such as saving time, reducing nursing costs, ensuring accuracy, and preventing contamination.

Prefilled syringes have four key components: a plunger, stopper, barrel, and a needle. The plunger and stopper must fit tightly inside of the barrel but should glide through it when pressure is applied. The syringes can be made of glass or an advanced polymer.

Competitive Analysis

Medtronic, Terumo Corporation, OMPI (A Stevanato Group Company¸ Vetter Pharma International GmbH, Abbott¸ Gerresheimer AG, Nipro Corporation, Baxter, Schott AG, West Pharmaceutical, Becton, Dickinson and Company, and Weigao Group, among others are some top-notch companies that are operating in the prefilled syringes market Players as listed by MRFR.

Market Segmentation

The segment assessment of the prefilled syringes market Outlook is based out type, end users, material, and design.

The type-based segments of the prefilled syringes market Trends are conventional prefilled syringes and safety prefilled syringes. The conventional prefilled syringes segment is expected to hold the largest share of market by 2024. 

The material-based segments of the prefilled syringe market are glass prefilled syringes and plastic prefilled syringes. The plastic syringes segment is expected to garner substantial revenue for the market. The expansion of the plastic syringe segment can be attributed to their increasing utility the pharmaceutical packaging. The glass prefilled syringes segment studies oil siliconized syringes and baked on silicone.

The design-based segments of the market are customized prefilled syringes, dual-chamber prefilled syringes, and single-chamber prefilled syringes. The Dual-chamber prefilled syringes segment can expand at 10.31% CAGR in the forecast tenure. The single-chamber prefilled syringes segment is likely to secure about 56% share for the overall prefilled syringe market by 2024.

The end-user-based segments of market are hospitals & clinics, and ambulatory surgical units among others. The hospitals segment is likely to grow with the rapid CAGR in the study period as the number of private and public hospitals are increasing.

Regional Analysis

In Europe, the prefilled syringe market can hold a decent share of the global market. Expansion of geriatric population, growing demand for better quality healthcare services and solutions, ongoing trend of home-based treatment, and hike in healthcare expenditure are causes that are likely to boost EU market. Similar causes are also observed as growth inducers in the Americas region. The Americas is likely to hold the second-largest market portion, following the Asia Pacific region. APAC prefilled syringe market can rise at 10.78% expansion rate in the forecast period. Moreover, factors such as, rapid adoption of plastic devices and modern healthcare developments are, expected to benefit the market in the review period. In the Middle East Asia, the surge in number of public hospitals and private clinics can promote the regional prefilled syringe market. market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Smart Insulin Pens Market Trends, Overview & Size by 2030

Smart Insulin Pens Market Highlights

The Smart Insulin Pens Market Size was worth USD 0.13 Billion in 2023 and is expected to reach USD 0.26 Billion by 2030 at 11.77% CAGR during the forecast period 2022 - 2030. As per smart insulin pens market analysts, the global market is anticipated to witness growth owing to the factors such as alarming escalation in diabetes cases as well as the escalating pool of diabetics considering surge in obesity. However, the smart insulin pens market will face challenges and restraints due to product recall and the amplified product quality issues during the forecast period 2022 to 2030.

Sedentary lifestyles and aging in the smart insulin pens market is set to play a key role in determining the growth potential during 2022 to 2030 years. Analysts have also studied the smart insulin pens market to understand potential threats and challenges the smart insulin pens market companies could face. Although the smart insulin pens market trends is poised to grow at a fast pace across product type and end-users’ segments, factors such as strict rules and regulations could slow down the smart insulin pens market's growth worldwide.

Competitive Landscape

Smart insulin pens have seen increased demand over the years, due to the commonness of unhealthy eating habits and lifestyles and the collective surge noted in product approvals. Companies functioning in the global smart insulin pens market are also being challenged due to stringent rules and concerns regarding the approval process. Mergers and acquisitions by smart insulin pens market companies are anticipated to help the market during the forecast period 2018 to 2023. As the smart insulin pens market is set to register a high CAGR of 6.92% and is also anticipated to reach a US$23,624.01 million by 2025, the report highlights key areas companies need to focus on. The report suggests that the smart insulin pens market will see a healthy growth in the long run till 2023. Based on SWOT analysis and smart insulin pens market’s analysis based on Porters’ Five Force Model presented in the smart insulin pens market report. Mergers and acquisitions by smart insulin pens market companies are anticipated to help the market during the forecast period 2018 to 2023. 

MRFR recognizes the Global Smart Insulin Pens Market Players are Companion Medical, Eli Lily and Company, Diamesco Co., Ltd., Ypsomed Holding AG, Emperra GmbH E-Health Technologies, Digital Medics Pty Ltd., and Novo Nordisk A/S and Others.

Market Segmentation

The market for smart insulin pens market insights has been segmented into product type and end-users. Based on the segment, which is product type, the market is categorized based on smart pen and connecting device. The global market for smart insulin pens is further segmented based on end-users into hospital/retail pharmacies and online.

The global market research report covers all the aspects of the smart insulin pens market based on the segmental analysis of these product types and end-users’ segments. Analysts have also studied the global smart insulin pens market's regional markets spread across many continents and countries. The product type and end-users’ segments along with their sub-segments have been analysed and companies functioning in the smart insulin pens market across these segments are profiled and analysed based on input and feedback from smart insulin pens industry-based decision makers as well as primary and secondary sources. The smart insulin pens market research report presents analysis-based information for companies functioning in the smart insulin pens market.

Regional Overview

New government rulings or hospital strategies in the wake of the pandemic may hinder the smart insulin pens market growth. The market research report suggests that companies in the smart insulin pens industry could be supported by broadening insurance coverage as well as the massive population suffering from diabetes during the forecast period. The smart insulin pens market is set to register growth at a high CAGR owing to these key factors. The market for smart insulin pens is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global smart insulin pens market research report reveals that APAC, North America, and Europe regional smart insulin pens markets will dominate the global market for smart insulin pens during the forecast period 2018 to 2023. As per smart insulin pens market analysts, the market is set to witness tremendous growth across devices as well as hospitals and clinics segments in North America which covers smart insulin pens markets across the United States, Canada, Mexico, and several other regional markets. Companies active in the smart insulin pens market are also analysed and studied in the smart insulin pens market research report.

The smart insulin pens industry for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the smart insulin pens market research report covers the Asia-Pacific region covering smart insulin pens markets from India, China, Japan, Australia, and others. The smart insulin pens market is also spread across the rest of the world. The smart insulin pens market report covers all such regions including the Middle East, Africa, Brazil, and others.

Industry News

Medtronic, a world pioneer in medical devices, revealed today that it will acquire privately owned Companion Medical, the maker of InPen, the only FDA-approved smart insulin pen device with an embedded diabetes care app on the marketplace. The inclusion of Companion Medical's InPen to Medtronic's portfolio broadens the company's potential to help patients at every stage in their disease path and provide them with a unique and vast ecosystem of assistance — independent of how insulin is administered. Companion Medical's acquisition draws on strong algorithms that take advantage of the corporation's deep data analytics and Artificial intelligence.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America